PolyPid Ltd.
No enriched coverage for $PYPD in the last 7 days.
No SEC Form 4 filings for $PYPD in the last 30 days.
PETACH TIKVA, Israel, Sept. 30, 2025 ( GLOBE NEWSWIRE ) -- PolyPid Ltd. ( NASDAQ:PYPD ) ( "PolyPid" or the "Company" ) , a late-stage biopharma company aiming to improve surgical outcomes, today announced that Dr. Shmuel Sharoni will present the topline results from the Company's successful ...
The Company will present the reported topline results from its phase 3 SHIELD II trial at one of the world's leading surgical conferences The Company will present the reported topline results from its phase 3 SHIELD II trial at one of the world's leading surgical conferences ...
PETACH TIKVA, Israel, Sept. 17, 2025 ( GLOBE NEWSWIRE ) -- PolyPid Ltd. PYPD ( "PolyPid" or the "Company" ) , a late-stage biopharma company aiming to improve surgical outcomes, today announced that management will be presenting at the Lytham Partners Fall 2025 Virtual Investor Conference on ...
